Latest news
Cabotegravir, Rilpivirine Outperforms Daily HIV Therapy in Adolescents - Drug TopicsDrug Topics · Tue, 04 Aug 2026 16:07:51 GMTCabenuva Beats Daily Oral Therapy in Adolescents With HIV in LATA Trial - Contagion LiveContagion Live · Tue, 04 Aug 2026 12:27:16 GMT[AIDS 2026] Infectious Disease Special Edition: Long-acting Cabenuva shows comparable real-world effectiveness to daily Biktarvy - European AIDS Treatment GroupEuropean AIDS Treatment Group · Sun, 02 Aug 2026 00:12:56 GMT[Press release] Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 - European AIDS Treatment GroupEuropean AIDS Treatment Group · Thu, 30 Jul 2026 00:44:02 GMTGSK's ViiV Healthcare Highlights New Long-Acting Injectable Data on Cabenuva in HIV Treatment - marketscreener.commarketscreener.com · Wed, 29 Jul 2026 16:33:25 GMTCabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 - GSKGSK · Wed, 29 Jul 2026 15:09:01 GMTLong-acting Cabenuva beats daily oral HIV therapy in adolescents | AIDS 2026 - Managed Healthcare ExecutiveManaged Healthcare Executive · Wed, 29 Jul 2026 07:00:00 GMT